Clinical Chemistry

Test Identifies Early Signs of Mucopolyscaccharidoses
Scientists have developed a test for identifying biomarkers for mucopolysaccharidoses, a group of inherited metabolic disorders that are currently diagnosed in patients only after symptoms have become serious and the damage possibly irreversible. More...16 Jan 2012
In Other News
Primary Screening Test for Diabetes Reevaluated
Biosensor Facilitates Early Diagnosis of Lung Cancer
Less Blood Needed for Postsurgical Transfusion
Blood Test Predicts Efficacy of Antidepressants
Liquid Cystatin C Assay– a Good Indicator of GFR
Thyroid Tests Overused During Psychiatric Admissions
Canine Blood Biomarkers Indicate Septic Infection in Humans Too
Vitamin D Assay Will Be Integrated into Existing Workflow
Assay Detects Single Molecules of Botulinum Toxin
Genomic Blood Test Excludes Coronary Heart Disease
Hemoglobin A1c Test Ineffective at Identifying Children with Diabetes
Cholesterol Check Recommended for all Young Children
Toxin Profiles Identified by Mass Spectrometry
Noninvasive Device Estimates Blood Sugar
Fecal Test Aids Colonoscopy Screening
Blood Test Measures Cancer Drug Efficacy
ELISA Detects Synthetic Cannabinoids in Urine and Blood
Urinary Eosinophils Commonly Found After Bladder Surgery
Blood Test for Cardiac Protein Diagnoses Heart Attack
Acute Hepatitis B Test Granted Premarket Approval
Blood Test Evaluates Risk of Preeclampsia
Breath Test Proposed to Diagnose Multiple Sclerosis
Blood Biomarker Blocks Repair and Contributes to Kidney Failure
The Clinical Chemistry channel updates the reader on tests, techniques, and research in the field - from routine assays to specialized tests on blood, urine, enzymes, lipids, hormones and more.








